Cite
HARVARD Citation
Stires, H. et al. (2018). Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Molecular and cellular endocrinology. pp. 105-117. [Online].